Form 4: M33 Growth I L.P. Acquires Shares and Warrants in Oncology Institute, Inc.
SEC Form 4
M33 Growth I L.P. purchased units consisting of common stock and warrants in Oncology Institute, Inc., resulting in changes in beneficial ownership.
Summary
- On March 26, 2025, M33 Growth I L.P. acquired 2,716,898 shares of Oncology Institute, Inc. common stock at $1.0417 per share.
- The purchase was part of a unit acquisition, with each unit also including a warrant.
- M33 Growth I L.P. also acquired 1,358,449 warrants to purchase shares of common stock at an exercise price of $1.1980 per share.
- The warrants are limited to ensure M33 Growth I L.P.'s beneficial ownership does not exceed 19.99% of the outstanding shares.
- M33 Growth I GP LLC, as the general partner of M33 Growth I L.P., may be deemed to beneficially own the shares held by M33 Growth I L.P.
- The purchase of the Units was approved by the Issuer's Board of Directors in accordance with Rule 16b-3 under the Securities Exchange Act of 1934, as amended.
Sentiment
Score: 7
Explanation: The sentiment is neutral to positive. It reflects a standard transaction with no immediately apparent red flags. The investment by M33 Growth I L.P. could be seen as a vote of confidence in Oncology Institute.
Positives
- The purchase of units was approved by the Issuer's Board of Directors in accordance with Rule 16b-3 under the Securities Exchange Act of 1934, as amended.
Risks
- The warrants are not exercisable to the extent that the exercise thereof would cause the reporting person to beneficially own greater than 19.99% of the outstanding shares of common stock of the Issuer.
Industry Context
This transaction reflects investment activity within the oncology sector, where companies are often targets for growth-focused investment firms.
Stakeholder Impact
- Shareholders may view the investment positively, as it could indicate confidence in the company's future prospects.
- The company now has a new major shareholder.
Key Dates
| Date | Description |
|---|---|
| 03/24/2025 | Securities Purchase Agreement date |
| 03/26/2025 | Date of transaction: purchase of common stock and warrants |
| 03/26/2030 | Expiration date of warrants |
| 03/28/2025 | Date of signature |
Keywords
Oncology Institute, M33 Growth I L.P., common stock, warrants, beneficial ownership, acquisition
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.